Detail akcie Becton Dickinson online

Business Summary: Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. It operates through five segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems, BD Interventional, and BD Life Sciences. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery. Its Life Sciences segment includes diagnostic solutions and biosciences.
Financial Summary: BRIEF: For the six months ended 31 March 2026, Becton Dickinson and Co revenues increased 3% to $9.97B. Net income before extraordinary items decreased 25% to $345M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Life Sciences segment income decrease of 79% to $159M, Medical segment income decrease of 45% to $569M.